A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2150933
Elevated glutamate levels are associated with glaucoma, and damage to retinal ganglion cells can be controlled by administering to the patient a compound capable of reducing glutamate induced excitotoxicity in a concentration effective to cause reduction of such excitotoxicity.
Dreyer Evan B.
Lipton Stuart A.
Massachusetts Eye And Ear Infirmary
Smart & Biggar
The Children's Medical Center Corporation
LandOfFree
Glaucoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glaucoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glaucoma treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1387972